Correspondence 0001493152-24-043781 from Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)

Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: Nov. 6, 2024 · CIK: 0001106838 · Accession: 0001493152-24-043781

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-282850

Date

November 6, 2024

Author

SONNET

Form

CORRESP

Company

Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)

Letter

Re: Sonnet BioTherapeutics Holdings, Inc.

November 6, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1

File No. 333-282850

Ladies and Gentlemen:

Sonnet BioTherapeutics Holdings, Inc. hereby requests that its acceleration request dated November 6, 2024 be withdrawn. Please call Steven M. Skolnick of Lowenstein Sandler LLP at 973-597-2476 with any questions.

Sincerely,
SONNET
BIOTHERAPEUTICS HOLDINGS, INC.

Show Raw Text

CORRESP
1
filename1.htm

November
6, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Sonnet
    BioTherapeutics Holdings, Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-282850

Ladies
and Gentlemen:

Sonnet
BioTherapeutics Holdings, Inc. hereby requests that its acceleration request dated November 6, 2024 be withdrawn. Please call Steven
M. Skolnick of Lowenstein Sandler LLP at 973-597-2476 with any questions.

    Sincerely,

    SONNET
    BIOTHERAPEUTICS HOLDINGS, INC.

    By:
    /s/
    Pankaj Mohan

    Name:
    Pankaj
    Mohan

    Title:
    Chief
    Executive Officer

SecProbe.io